Development of a rapid identification method for Klebsiella pneumoniae phylogenetic groups and analysis of 420 clinical isolates

Clinical Microbiology and Infection

Volumn 10, Issue 10, 2004, Pages 942-945

  Brisse, S ^a,b   van Himbergen, T ^b   Kusters, K ^b   Verhoef, J ^b  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Epidemiology; Identification; Klebsiella pneumoniae; Klebsiella variicola; Resistance

Indexed keywords

AMIKACIN; AMPICILLIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; DNA TOPOISOMERASE (ATP HYDROLYSING); GENTAMICIN; IMIPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PROTEIN PARC;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOOD SAMPLING; CONTROLLED STUDY; GENE SEQUENCE; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

KLEBSIELLA; KLEBSIELLA PNEUMONIAE; KLEBSIELLA VARIICOLA;

EID: 6444222944     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2004.00973.x     Document Type: Article

References (13)

1. Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998; 11: 589-603.
2. Grimont F, Grimont PAD, Richard C. The genus Klebsiella. In: Balows A, Trüper HG, Dworkin M, Harder W, Schleifer K-H, eds. The prokaryotes. New York: Springer-Verlag, 1992; 2775-2796.
3. Babini GS, Livermore DM. Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998. J Antimicrob Chemother 2000; 45: 183-189.
4. Brisse S, Milatovic D, Fluit AC, Verhoef J, Schmitz FJ. Epidemiology of quinolone resistance of Klebsiella pneumoniae and Klebsiella oxytoca in Europe. Eur J Clin Microbiol Infect Dis 2000; 19: 64-68.
5. Livermore DM, Yuan M. Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe. J Antimicrob Chemother 1996; 38: 409-424.
6. Sirot J, Nicolas-Chanoine MH, Chardon H et al. Susceptibility of Enterobacteriaceae to beta-lactam agents and fluoroquinolones: a 3-year survey in France. Clin Microbiol Infect 2002; 8: 207-213.
7. Brisse S, Verhoef J. Phylogenetic diversity of Klebsiella pneumoniae and Klebsiella oxytoca clinical isolates revealed by randomly amplified polymorphic DNA, gyrA and parC genes sequencing and automated ribotyping. Int J Syst Evol Microbiol 2001; 51: 915-924.
8. Rosenblueth M, Martínez L, Silva J, Martínez-Romero E. Klebsiella variicola, a novel species with clinical and plant-associated isolates. Syst Appl Microbiol 2004; 27: 27-35.
9. Jones ME, Jones RN, Sader H, Verhoef J, Acar J. Current susceptibilities of staphylococci to glycopeptides determined as part of an international resistance surveillance programme. Sentry Antimicrobial Surveillance Program. J Antimicrob Chemother 1998; 42: 119-121.
10. Monnet D, Freney J, Brun Y, Boeufgras JM, Fleurette J. Difficulties in identifying Klebsiella strains of clinical origin. Zentralbl Bakteriol 1991; 274: 456-464.
11. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial tests for bacteria that grow aerobically. Approved standard M7-A4. Wayne, PA: NCCLS, 1997.
12. Montgomerie JZ. Epidemiology of Klebsiella pneumoniae and hospital-associated infections. Rev Infect Dis 1979; 1: 736-753.
13. Selden R, Lee S, Wang WL, Bennett JV, Eickhoff TC. Nosocomial Klebsiella infections: intestinal colonization as a reservoir. Ann Intern Med 1971; 74: 657-664.